세계의 OTC(Over-The-Counter) 인공눈물 시장 보고서(2025년)
Over-The-Counter (OTC) Artificial Tears Global Market Report 2025
상품코드 : 1810989
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

OTC(Over-The-Counter) 인공눈물 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 61억 9,000만 달러로 성장하며, CAGR은 5.8%에 달합니다. 예측 기간의 성장은 방부제가 없는 제제에 대한 수요 증가, 젊은 층의 디지털 기기 사용 확대, 셀프 케어 안과 치료 선호도 증가, 온라인 약국 네트워크 확대, 알레르기 관련 안구건조증 증가 등이 견인할 것으로 예측됩니다. 이 기간 중 예상되는 주요 동향으로는 눈물 제제의 기술 발전, 히알루론산과 지질을 통합한 제품의 혁신, 지속가능한 포장 개발, 무약물 안구윤활유 연구, 스마트 디스펜서와 투약 시스템 통합 등이 있습니다.

안질환 유병률 증가는 향후 일반의약품(OTC) 인공눈물 시장의 성장을 촉진할 것으로 예측됩니다. 안질환은 눈의 정상적인 기능과 구조에 영향을 미치는 병으로, 방치하면 시력장애나 시력상실을 유발할 수 있습니다. 안질환 발생이 증가하는 주요 원인은 인구 고령화로 인해 시력 문제가 발생하기 쉬워지고 있으며, 이에 따라 첨단 아이케어 솔루션에 대한 수요가 증가하고 있습니다. OTC 인공눈물은 안구 건조를 완화하고, 자극을 줄이고, 눈 표면을 보호하여 전반적인 눈의 편안함을 향상시키며, 부드러운 윤활을 제공하여 안구 질환 관리에 도움을 줍니다. 예를 들어 검안사 협회가 2023년 9월에 발표한 보고서에 따르면 2022년 영국에서 2만 2,552건의 시력 장애가 새로 인정된 것으로 나타났습니다. 이 중 1,344건은 당뇨병성 안질환, 3,614건은 녹내장, 1,865건은 노인황반변성으로 인한 것입니다. 따라서 안질환 유병률 증가는 OTC 인공눈물 시장의 확대에 박차를 가하고 있습니다.

OTC 인공눈물 시장의 주요 기업은 효과적이고 장기적인 치료 효과를 제공하기 위해 지질층 안정화 제제와 같은 첨단 무방부제 제제 개발에 주력하고 있습니다. 지질층 안정화 제제는 눈물막 바깥쪽의 유성층을 강화하여 눈물의 급격한 증발을 방지하고 눈의 수분을 유지하는데 도움을 줍니다. 2025년 2월, 스위스에 본사를 둔 아이케어 기업 알콘(Alcon)은 건조한 눈을 보습, 회복, 보호하는 3중 작용을 하는 OTC 인공눈물 '시스테인 프로 방부제 프리(PF)'를 출시했습니다. 이 제품은 히알루론산, 나노 크기의 지질, HP-Guar를 함유한 혁신적인 다중 용량 무방부제 설계로 눈물막을 안정화시키고 눈 표면을 보호하여 모든 유형의 안구건조증을 장기적으로 완화하고 잦은 사용에도 자극을 최소화합니다. 자극을 최소화합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Over-the-counter artificial tears are eye drops available without a prescription, created to soothe and moisturize eyes experiencing dryness, irritation, or discomfort due to factors like environmental exposure, prolonged digital screen use, or conditions such as dry eye syndrome. These drops offer fast, convenient relief and are commonly used for everyday eye hydration.

The primary categories of OTC artificial tears include cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, and polyethylene glycol-based tears. Cellulose-derived tears contain cellulose-based polymers designed to replicate natural tears, providing extended moisture and lubrication for dry or irritated eyes. These products come in various container types, such as plastic single-dose and multi-dose containers. Formulations can be either preservative-based or preservative-free, and they are applied in treatments for dry eye syndrome, allergies, infections, UV and blue light protection, contact lens moisture retention, and more. Major distribution channels include hospital pharmacies, drugstores and retail pharmacies, as well as online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The over-the-counter (OTC) artificial tears market research report is one of a series of new reports from The Business Research Company that provides over-the-counter (OTC) artificial tears market statistics, including the over-the-counter (OTC) artificial tears industry global market size, regional shares, competitors with the over-the-counter (OTC) artificial tears market share, detailed over-the-counter (OTC) artificial tears market segments, market trends, and opportunities, and any further data you may need to thrive in the over-the-counter (OTC) artificial tears industry. This over-the-counter (OTC) artificial tears market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over-the-counter (OTC) artificial tears market size has grown strongly in recent years. It will grow from $4.66 billion in 2024 to $4.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. Growth during the historic period can be credited to the rising prevalence of dry eye syndrome, increased screen time among working professionals, heightened awareness of eye hygiene, a growing elderly population with eye-related issues, and greater retail accessibility of eye care products.

The over-the-counter (OTC) artificial tears market size is expected to see strong growth in the next few years. It will grow to $6.19 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. Growth in the forecast period is expected to be driven by increasing demand for preservative-free formulations, greater digital device usage among younger populations, a growing preference for self-care eye treatments, the expansion of online pharmacy networks, and a rise in allergy-related eye dryness. Key trends anticipated during this period include technological advancements in tear formulations, product innovations incorporating hyaluronic acid and lipids, the development of sustainable packaging, research into drug-free eye lubricants, and the integration of smart dispensers and dosage systems.

The rising prevalence of eye diseases is expected to drive the growth of the over-the-counter (OTC) artificial tears market in the future. Eye diseases are conditions that affect the normal function or structure of the eye, potentially causing vision impairment or loss if left untreated. The increasing occurrence of eye diseases is mainly due to aging populations, who are more susceptible to vision issues, thereby creating a higher demand for advanced eye care solutions. OTC artificial tears help manage eye diseases by providing soothing lubrication that alleviates dryness, reduces irritation, and protects the ocular surface to enhance overall eye comfort. For example, a report published by the Association of Optometrists in September 2023 stated that in 2022, England recorded 22,552 new certifications for vision impairment. Of these, 1,344 were attributed to diabetic eye disease, 3,614 to glaucoma, and 10,865 to age-related macular degeneration. Hence, the growing prevalence of eye diseases is fueling the expansion of the OTC artificial tears market.

Leading companies in the OTC artificial tears market are concentrating on developing advanced preservative-free formulations, such as lipid layer stabilization formulas, to deliver effective and prolonged relief. Lipid layer stabilization strengthens the outer oily layer of the tear film, which prevents rapid tear evaporation and helps maintain eye moisture. In February 2025, Alcon Inc., a Switzerland-based eye care company, introduced SYSTANE PRO Preservative-Free (PF), an OTC artificial tear with a triple-action formula designed to hydrate, restore, and protect dry eyes. This product features an innovative multi-dose, preservative-free design that combines hyaluronate, nano-sized lipids, and HP-Guar, which work together to deeply hydrate, stabilize the tear film, and shield the ocular surface, providing long-lasting relief for all types of dry eye while minimizing irritation, even with frequent use.

In July 2023, Bausch + Lomb Corporation, a Canada-based eye health company, acquired the Blink OTC eye drop product line from Johnson & Johnson Vision for $106.5 million. This acquisition aims to bolster Bausch + Lomb's OTC eye care portfolio by incorporating the Blink range of artificial tears and rewetting drops, thereby expanding consumer access to trusted products for dry eye and contact lens discomfort. Johnson & Johnson Vision, based in the US, manufactures OTC artificial tears designed to relieve dry eye symptoms and enhance comfort for contact lens users.

Major players in the over-the-counter (otc) artificial tears market are AbbVie Inc., Abbott Laboratories Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., CooperVision Inc., Cipla Limited, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Limited, URSAPHARM Arzneimittel GmbH, OCuSOFT Inc., OASIS Medical Inc., NovaBay Pharmaceuticals Inc., Laboratoires Thea S.A.S., GBN Pharmaceuticals, I-MED Pharma Inc., Opdenas Lifesciences.

North America was the largest region in the over-the-counter (OTC) artificial tears market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in over-the-counter (OTC) artificial tears report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over-the-counter (OTC) artificial tears market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) artificial tears market consists of sales of hyaluronic acid-based tears, electrolyte-based tears, vitamin-enriched tears, medium viscosity tears, and high viscosity tears. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over-The-Counter (OTC) Artificial Tears Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over-the-counter (otc) artificial tears market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for over-the-counter (otc) artificial tears ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over-the-counter (otc) artificial tears market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Over-The-Counter (OTC) Artificial Tears Market Characteristics

3. Over-The-Counter (OTC) Artificial Tears Market Trends And Strategies

4. Over-The-Counter (OTC) Artificial Tears Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Over-The-Counter (OTC) Artificial Tears Growth Analysis And Strategic Analysis Framework

6. Over-The-Counter (OTC) Artificial Tears Market Segmentation

7. Over-The-Counter (OTC) Artificial Tears Market Regional And Country Analysis

8. Asia-Pacific Over-The-Counter (OTC) Artificial Tears Market

9. China Over-The-Counter (OTC) Artificial Tears Market

10. India Over-The-Counter (OTC) Artificial Tears Market

11. Japan Over-The-Counter (OTC) Artificial Tears Market

12. Australia Over-The-Counter (OTC) Artificial Tears Market

13. Indonesia Over-The-Counter (OTC) Artificial Tears Market

14. South Korea Over-The-Counter (OTC) Artificial Tears Market

15. Western Europe Over-The-Counter (OTC) Artificial Tears Market

16. UK Over-The-Counter (OTC) Artificial Tears Market

17. Germany Over-The-Counter (OTC) Artificial Tears Market

18. France Over-The-Counter (OTC) Artificial Tears Market

19. Italy Over-The-Counter (OTC) Artificial Tears Market

20. Spain Over-The-Counter (OTC) Artificial Tears Market

21. Eastern Europe Over-The-Counter (OTC) Artificial Tears Market

22. Russia Over-The-Counter (OTC) Artificial Tears Market

23. North America Over-The-Counter (OTC) Artificial Tears Market

24. USA Over-The-Counter (OTC) Artificial Tears Market

25. Canada Over-The-Counter (OTC) Artificial Tears Market

26. South America Over-The-Counter (OTC) Artificial Tears Market

27. Brazil Over-The-Counter (OTC) Artificial Tears Market

28. Middle East Over-The-Counter (OTC) Artificial Tears Market

29. Africa Over-The-Counter (OTC) Artificial Tears Market

30. Over-The-Counter (OTC) Artificial Tears Market Competitive Landscape And Company Profiles

31. Over-The-Counter (OTC) Artificial Tears Market Other Major And Innovative Companies

32. Global Over-The-Counter (OTC) Artificial Tears Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over-The-Counter (OTC) Artificial Tears Market

34. Recent Developments In The Over-The-Counter (OTC) Artificial Tears Market

35. Over-The-Counter (OTC) Artificial Tears Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기